SPDR S&P Biotech ETF (XBI) Dividend History

Dividend History

Pay Date Amount Ex Dividend Date Record Date
March 26, 2025 $0.01 03/24/2025 03/24/2025
December 26, 2024 $0.00 12/23/2024 12/23/2024
September 25, 2024 $0.02 09/23/2024 09/23/2024
June 26, 2024 $0.11 06/24/2024 06/24/2024
December 21, 2023 $0.01 12/18/2023 12/19/2023
Show more

Dividends Summary

  • SPDR S&P Biotech ETF has issued 43 dividend payments over the past 18 years
  • The most recent dividend was paid 73 days ago, on March 26, 2025
  • The first recorded dividend was paid on June 27, 2007
  • The highest dividend payout was $0.67 per share
  • The average dividend over this 18 year span is $0.12 per share
  • SPDR S&P Biotech ETF has decreased its dividend payments by 96.16% since 2007

Company News

  • 'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds

    Bank of America's chief investment strategist Michael Hartnett recommends buying long-duration bonds as yields stabilize and the potential for lower government deficits under the Trump administration. He suggests four ETFs to watch: iShares 20+ Year Treasury Bond ETF (TLT), SPDR S&P Biotech ETF (XBI), SPDR Homebuilders ETF (XHB), and SPDR Utilities Select Sector Fund (XLU).

    Benzinga
    Featured Companies: TLT XHB XLU
  • 2 Biotech Stocks to Buy Hand Over Fist in December

    The biotech industry has lagged the broader market in 2024, but CRISPR Therapeutics and Exelixis still look like solid long-term picks. CRISPR Therapeutics has a promising gene-editing therapy, while Exelixis' cancer drug Cabometyx continues to drive strong financial results.

    The Motley Fool
    Featured Companies: CRSP EXEL
  • Is Biotech’s Bull Run Over? Examining Election Impacts

    The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. The appointment of RFK Jr. to lead the Department of Health and Human Services has spooked investors with his controversial policies and vaccine skepticism, leading to a decline in sector giants like Pfizer.

    Investing.com
    Featured Companies: IBB MRNA NVAX PFE
  • 8 Charts Suggesting Stock Market Pullback Could Deepen in the Near-Term

    The article discusses 8 technical charts that suggest the stock market could see a deeper pullback in the near-term, including signs of a potential island reversal top in the S&P 500, a diamond top or head and shoulders pattern in the Nasdaq 100, and weakness in high-yield bonds and biotech stocks.

    Investing.com
    Featured Companies: ADBE HYG QQQM
  • Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

    The First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange-traded fund that provides broad exposure to the healthcare-biotech sector. The ETF tracks the NYSE Arca Biotechnology Index and has a relatively high expense ratio of 0.56%. Its top holdings include Alnylam Pharmaceuticals, Corcept Therapeutics, and United Therapeutics.

    Zacks Investment Research
    Featured Companies: ALNY CORT FBT IBB UTHR
Dividend data last updated 06/07/2025 15:01:11 UTC